Antithrombotic Therapy Post Endovascular Stenting for Superior Vena Cava Syndrome
Superior vena cava syndrome results in obstruction of the superior vena cava and commonly requires intervention. Stents are often used to increase the patency of the vena cava and to prevent reocclusion. The role of antithrombotic therapy and agents to use has been highly debated due to stent location, hematologic complications, and limited clinical evidence available on the topic. This commentary seeks to determine the appropriate choice, if any, for antithrombotic therapy after superior vena cava stent placement.
Sheena L. Hayes, Sara Lott, Michael J. Scalese*
To read the full article Download Full Article | Visit Full Article
Menu